High-resolution melting analysis assay for identification of Fonsecaea species
- PMID: 28543666
- PMCID: PMC6817294
- DOI: 10.1002/jcla.22257
High-resolution melting analysis assay for identification of Fonsecaea species
Abstract
Background: Chromoblastomycosis (CBM) is a chronic fungal disease. In China, the principle etiologic agent was a group of dematiaceous fungi, including Fonsecaea monophora, Fonsecaea nubica, and Cladophialophora carrionii. Although the Fonsecaea species have similar morphology, their pathogenicity is quite different. This study aims to establish a new solution for early identification of Fonsecaea species because of their distinctive potential infection risk.
Methods: Five reference strains and 35 clinical isolates from patients with CBM, preserved in our laboratory, were used in this study. The universal primer ITS1 and ITS2 were chosen to amplify the highly conserved regions of rDNA. High-resolution melting (HRM) analysis was performed using the LIGHTCYCLER® 96 System. All the amplicons were verified by direct sequencing and the sequence were aligned with those in GenBank by BLAST analysis.
Results: We successfully differentiated the five strains according to their different Tm values and curve shapes. The 35 clinical isolates from patients were identified as 24 strains for F. monophora and 11 strains for F. nubica, which is consistent with the DNA sequencing results.
Conclusion: It is the first time to use HRM analysis for identification of Fonsecaea species. Since the CBM etiologic agent in South China is mainly F. monophora and F. nubica, this strategy is sufficient to be applied in the clinical examination with high accuracy, speed, and throughput.
Keywords: Fonsecaea species; chromoblastomycosis; high-resolution melting; identification.
© 2017 Wiley Periodicals, Inc.
Figures


Similar articles
-
Chromoblastomycosis Caused by Fonsecaea nubica: First Report in Northern China and Literature Review.Mycopathologia. 2019 Feb;184(1):97-105. doi: 10.1007/s11046-018-0307-0. Epub 2018 Dec 13. Mycopathologia. 2019. PMID: 30547378 Review.
-
Molecular identification of chromoblastomycosis clinical isolates in Guangdong.Med Mycol. 2017 Nov 1;55(8):851-858. doi: 10.1093/mmy/myw140. Med Mycol. 2017. PMID: 28053146
-
Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.Med Mycol. 2009 Feb;47(1):27-33. doi: 10.1080/13693780802468209. Epub 2008 Oct 25. Med Mycol. 2009. PMID: 18951291
-
Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.Med Mycol. 2010 Sep;48(6):800-6. doi: 10.3109/13693780903503081. Med Mycol. 2010. PMID: 20302550
-
A case of cerebral phaeohyphomycosis caused by Fonsecaea monophora, a neurotropic dematiaceous fungus, and a review of the literature.Mycoses. 2015 Mar;58(3):187-92. doi: 10.1111/myc.12290. Epub 2015 Jan 15. Mycoses. 2015. PMID: 25591071 Review.
Cited by
-
Isolation and molecular characterization of clinical and environmental dematiaceous fungi and relatives from Iran.Curr Med Mycol. 2021 Sep;7(3):1-8. doi: 10.18502/cmm.7.3.7798. Curr Med Mycol. 2021. PMID: 35528626 Free PMC article.
-
Chromoblastomycosis Caused by Fonsecaea nubica: First Report in Northern China and Literature Review.Mycopathologia. 2019 Feb;184(1):97-105. doi: 10.1007/s11046-018-0307-0. Epub 2018 Dec 13. Mycopathologia. 2019. PMID: 30547378 Review.
-
[Long-pulsed 1064 nm Nd: YAG laser combined with terbinafine against chromoblastomycosis caused by Fonsecaea nubica and the effect of laser therapy in a Wistar rat model].Nan Fang Yi Ke Da Xue Xue Bao. 2019 Jun 30;39(6):712-717. doi: 10.12122/j.issn.1673-4254.2019.06.13. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 31270051 Free PMC article. Chinese.
-
Role of Dectin-1 in immune response of macrophages induced by Fonsecaea monophora wild strain and melanin-deficient mutant strain.Mycology. 2023 Sep 3;15(1):45-56. doi: 10.1080/21501203.2023.2249010. eCollection 2024. Mycology. 2023. PMID: 38558842 Free PMC article.
References
-
- Santos AL, Palmeira VF, Rozental S, et al. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis. FEMS Microbiol Rev. 2007;31:570‐591. - PubMed
-
- Queiroz‐Telles F, Esterre P, Perez‐Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47:3‐15. - PubMed
-
- Lu S, Lu C, Zhang J, Hu Y, Li X, Xi L. Chromoblastomycosis in Mainland China: a systematic review on clinical characteristics. Mycopathologia. 2013;175:489‐495. - PubMed
-
- Didehdar M, Khansarinejad B, Amirrajab N, Shokohi T. Development of a high‐resolution melting analysis assay for rapid and high‐throughput identification of clinically important dermatophyte species. Mycoses. 2016;59:442‐449. - PubMed
-
- Alnuaimi AD, Wiesenfeld D, O'Brien‐Simpson NM, Reynolds EC, Peng B, McCullough MJ. The development and validation of a rapid genetic method for species identification and genotyping of medically important fungal pathogens using high‐resolution melting curve analysis. Mol Oral Microbiol. 2014;29:117‐130. - PubMed
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials